Par Drugs & Che.

{
  "main_header": {
    "sid": 1003142,
    "name": "Par Drugs & Che.",
    "stock_name": "Par Drugs & Che.",
    "full_name": "Par Drugs & Chemicals Ltd",
    "name_url": "stocks-analysis/par-drugs-che",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "100.40",
    "chg": -3.13,
    "chgp": "-3.02%",
    "dir": -1,
    "prev_price": "103.53",
    "mcapval": "127.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "PAR",
    "ind_name": "Chemicals & Petrochemicals",
    "ind_code": 11,
    "sector_id": 10,
    "indexname": "India SENSEX",
    "isin": "INE04LG01015",
    "curr_date": "Aug 11, 03:30 PM",
    "curr_time": "21:00 PM",
    "last_traded_at": "Aug 11, 03:30 PM IST",
    "bse_nse_vol": 15069,
    "exc_status": "Active",
    "traded_date": "Aug 11, 2026",
    "traded_date_str": "2026 08 11",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/par-drugs-che-1003142-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Golden Cross Confirmed: Do Par Drugs & Chemicals Ltd's Other Technical Indicators Agree?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/par-drugs-chemicals-ltd-forms-golden-cross-signalling-potential-bullish-breakout-4148031",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ParDrugsChemica_goldencross_4148031.png",
        "date": "2026-08-11 18:15:35",
        "description": "The 50-day moving average has crossed above the 200-day moving average for Par Drugs & Chemicals Ltd, signalling a golden cross on 11 Jun 2026. Yet, the stock declined 3.02% on the day this crossover occurred, while monthly indicators remain only mildly bullish or neutral. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability."
      },
      {
        "title": "Par Drugs & Chemicals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-hold-4145213",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ParDrugsChemica_mojoScore_4145213.png",
        "date": "2026-08-10 10:10:22",
        "description": "Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 8 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with the most up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Par Drugs & Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/par-drugs-chemicals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4144611",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/ParDrugsChemica_valuationdot_4144611.png",
        "date": "2026-08-10 08:02:08",
        "description": "Par Drugs & Chemicals Ltd has witnessed a significant improvement in its valuation parameters, transitioning from a very expensive rating to a fair valuation grade. This shift, driven primarily by a marked reduction in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positions the micro-cap chemical company as a more attractive proposition relative to its historical levels and peer group benchmarks."
      },
      {
        "title": "Par Drugs & Chemicals Ltd Valuation Improves Amid Market Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/par-drugs-chemicals-ltd-valuation-improves-amid-market-volatility-4129475",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParDrugsChemica_valuationdot_4129475.png",
        "date": "2026-07-31 08:01:04",
        "description": "Par Drugs & Chemicals Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, reflecting a positive change in market perception. With a current price of ₹99.30 and a recent day gain of 3.61%, the micro-cap chemical company is showing signs of renewed investor confidence amid a challenging sector backdrop."
      },
      {
        "title": "Par Drugs & Chemicals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-hold-4128500",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParDrugsChemica_mojoScore_4128500.png",
        "date": "2026-07-30 10:11:00",
        "description": "Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date view of its performance and outlook."
      },
      {
        "title": "Par Drugs & Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/par-drugs-chemicals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4108437",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParDrugsChemica_valuationdot_4108437.png",
        "date": "2026-07-20 08:01:24",
        "description": "Par Drugs & Chemicals Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating. This change reflects a recalibration of price multiples such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap chemical company more favourably against its peers and historical benchmarks."
      },
      {
        "title": "Par Drugs & Chemicals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-hold-4107953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParDrugsChemica_mojoScore_4107953.png",
        "date": "2026-07-19 10:10:27",
        "description": "Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Par Drugs & Chemicals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-sell-4093528",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/ParDrugsChemica_mojoScore_4093528.png",
        "date": "2026-07-08 10:10:04",
        "description": "Par Drugs & Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Par Drugs & Chemicals Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/par-drugs-chemicals-ltd-is-rated-sell-4075043",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ParDrugsChemica_mojoScore_4075043.png",
        "date": "2026-06-27 10:10:03",
        "description": "Par Drugs & Chemicals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 137,
    "sid": "1003142",
    "stock_news_url": "https://www.marketsmojo.com/news/par-drugs-chemicals-1003142"
  },
  "announcements": [
    {
      "details": "Par Drugs And Chemicals Limited has informed the Exchange regarding Board meeting held on November 11, 2019.",
      "source": "NSE",
      "caption": "Par Drugs And Chemicals Limited - Outcome of Board Meeting",
      "datetime": "13-Nov-2019"
    },
    {
      "details": "Par Drugs And Chemicals Limited has informed the Exchange that the Company has fixed Record Date as November 25, 2019 for the purpose of INTERIM DIVIDEND",
      "source": "NSE",
      "caption": "Par Drugs And Chemicals Limited - Record Date",
      "datetime": "04-Nov-2019"
    },
    {
      "details": "Par Drugs And Chemicals Limited has informed the Exchange regarding 'WHO-GMP Certification'.",
      "source": "NSE",
      "caption": "Par Drugs And Chemicals Limited - Updates",
      "datetime": "30-Oct-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Par Drugs & Chemicals Ltd has declared <strong>12%</strong> dividend, ex-date: 22 Nov 21",
          "dt": "2021-11-22",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Par Drugs & Chemicals Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 27 Apr 21",
          "dt": "2021-04-27",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Golden Cross Confirmed: Do Par Drugs & Chemicals Ltd's Other Technical Indicators Agree?

2026-08-11 18:15:35

The 50-day moving average has crossed above the 200-day moving average for Par Drugs & Chemicals Ltd, signalling a golden cross on 11 Jun 2026. Yet, the stock declined 3.02% on the day this crossover occurred, while monthly indicators remain only mildly bullish or neutral. This divergence between the moving averages and price action calls for a detailed examination of the signal's reliability.

Read full news article

Par Drugs & Chemicals Ltd is Rated Hold

2026-08-10 10:10:22

Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 8 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Read full news article

Par Drugs & Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-08-10 08:02:08

Par Drugs & Chemicals Ltd has witnessed a significant improvement in its valuation parameters, transitioning from a very expensive rating to a fair valuation grade. This shift, driven primarily by a marked reduction in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positions the micro-cap chemical company as a more attractive proposition relative to its historical levels and peer group benchmarks.

Read full news article

Par Drugs & Chemicals Ltd Valuation Improves Amid Market Volatility

2026-07-31 08:01:04

Par Drugs & Chemicals Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating, reflecting a positive change in market perception. With a current price of ₹99.30 and a recent day gain of 3.61%, the micro-cap chemical company is showing signs of renewed investor confidence amid a challenging sector backdrop.

Read full news article

Par Drugs & Chemicals Ltd is Rated Hold

2026-07-30 10:11:00

Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 28 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date view of its performance and outlook.

Read full news article

Par Drugs & Chemicals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-07-20 08:01:24

Par Drugs & Chemicals Ltd has witnessed a notable improvement in its valuation parameters, shifting from a very attractive to an attractive rating. This change reflects a recalibration of price multiples such as the price-to-earnings (P/E) and price-to-book value (P/BV) ratios, positioning the micro-cap chemical company more favourably against its peers and historical benchmarks.

Read full news article

Par Drugs & Chemicals Ltd is Rated Hold

2026-07-19 10:10:27

Par Drugs & Chemicals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 16 July 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 19 July 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Par Drugs & Chemicals Ltd is Rated Sell

2026-07-08 10:10:04

Par Drugs & Chemicals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Par Drugs & Chemicals Ltd is Rated Sell

2026-06-27 10:10:03

Par Drugs & Chemicals Ltd is rated Sell by MarketsMOJO, with this rating last updated on 15 May 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 27 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

View All News